These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 21328680

  • 1. DES in SVGs: safe and at least short-term effective.
    Hillegass WB.
    Catheter Cardiovasc Interv; 2011 Feb 15; 77(3):356-7. PubMed ID: 21328680
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients.
    Hakeem A, Helmy T, Munsif S, Bhatti S, Mazraeshahi R, Cilingiroglu M, Effat M, Leesar M, Arif I.
    Catheter Cardiovasc Interv; 2011 Feb 15; 77(3):343-55. PubMed ID: 21328679
    [Abstract] [Full Text] [Related]

  • 3. Are our patients better off with drug-eluting stents in saphenous vein grafts?
    Douglas JS.
    JACC Cardiovasc Interv; 2009 Nov 15; 2(11):1113-5. PubMed ID: 19926053
    [No Abstract] [Full Text] [Related]

  • 4. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, Humphrey A, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA, STENT Group.
    JACC Cardiovasc Interv; 2009 Nov 15; 2(11):1105-12. PubMed ID: 19926052
    [Abstract] [Full Text] [Related]

  • 5. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES, Lichtenwalter C, Abdel-karim AR, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S.
    JACC Cardiovasc Interv; 2011 Feb 15; 4(2):176-82. PubMed ID: 21349456
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ, Gaffigan M, Berrio G, Plessa AL, Pfeiffer AM, Markwell SJ, Mishkel GJ.
    Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):93-100. PubMed ID: 19787803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts.
    Nauta ST, Van Mieghem NM, Magro M, Deckers JW, Simsek C, Van Geuns RJ, Van Der Giessen WJ, De Jaegere P, Regar E, Van Domburg RT, Serruys PW.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):912-8. PubMed ID: 21542111
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis.
    Sanchez-Recalde A, Jiménez Valero S, Moreno R, Barreales L, Lozano I, Galeote G, Martín Reyes R, Calvo L, Lopez-Sendon JL.
    EuroIntervention; 2010 May 01; 6(1):149-60. PubMed ID: 20542811
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, Saeed B, Iturbe JM, Shunk K, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES.
    JACC Cardiovasc Interv; 2009 Sep 01; 2(9):855-60. PubMed ID: 19778774
    [Abstract] [Full Text] [Related]

  • 16. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.
    Lee MS, Hu PP, Aragon J, Shah A, Bhatia R, Jones N, Penny W, French W, Tobis J, Mahmud E.
    Catheter Cardiovasc Interv; 2010 Aug 01; 76(2):272-8. PubMed ID: 20623716
    [Abstract] [Full Text] [Related]

  • 17. Drug-eluting stents for saphenous vein graft lesions.
    Hakeem A, Helmy T, Leesar M, Arif I.
    JACC Cardiovasc Interv; 2011 May 01; 4(5):590; author reply 591-3. PubMed ID: 21596336
    [No Abstract] [Full Text] [Related]

  • 18. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
    Hoffmann R, Nitendo G, Deserno V, Adamu U, Almalla M, Blindt R, Vogt F.
    Coron Artery Dis; 2010 Mar 01; 21(2):61-4. PubMed ID: 20124993
    [Abstract] [Full Text] [Related]

  • 19. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R, Alfonso F, Jimenez P.
    EuroIntervention; 2009 May 01; 5 Suppl D():D51-7. PubMed ID: 19736072
    [Abstract] [Full Text] [Related]

  • 20. Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions.
    Yazdani SK, Farb A, Nakano M, Vorpahl M, Ladich E, Finn AV, Kolodgie FD, Virmani R.
    JACC Cardiovasc Interv; 2012 Jun 01; 5(6):666-74. PubMed ID: 22721663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.